Answers are grounded in this paper and cite their sources.
Analysis of targeted panels finds insufficient biomarker coverage in mNSCLC, suggesting improvement needs.
Of 77 unique panels evaluated, only 5 captured all recommended biomarkers for mNSCLC. Ensuring targeted panels assess all relevant biomarkers is crucial for optimal patient treatment.
No takes yet. Share an insight, caveat, or question.
Reynolds et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: